journal
https://read.qxmd.com/read/38574519/venous-thromboembolism-vte-developing-after-ankle-sprain-comparison-with-vte-after-knee-arthroplasty
#21
REVIEW
Javier Gutiérrez-Guisado, Alejo Erice Calvo-Sotelo, Luis Hernández-Blasco, Ángeles Fidalgo, Covadonga Gómez-Cuervo, Antonio López-Ruiz, Jesús Aibar, Peter Verhamme, José Meireles, Manuel Monreal
BACKGROUND: Venous thromboembolism (VTE) is a critical complication after non-major trauma or surgery. While the risk and severity of VTE following major orthopedic surgery is well-documented, there is significant knowledge gap regarding, non-major trauma such as ankle sprains. METHODS: We analyzed data from the RIETE registry to assess the clinical characteristics, VTE prophylaxis usage, and outcomes in patients with VTE following ankle sprain versus those post elective knee arthroplasty...
March 21, 2024: Thrombosis Research
https://read.qxmd.com/read/38547690/mucin-1-and-venous-thrombosis-in-tumor-bearing-mice-and-patients-with-cancer
#22
JOURNAL ARTICLE
Tomohiro Kawano, Cornelia Englisch, Yohei Hisada, David Paul, Sierra Archibald, Steven Grover, Ingrid Pabinger, Cihan Ay, Nigel Mackman
INTRODUCTION: Mucins released from epithelial tumors have been proposed to play a role in cancer-associated thrombosis. Mucin1 (MUC1) is a transmembrane mucin that is overexpressed in a variety of human malignancies, including breast and pancreatic cancer. We analyzed the association of MUC1 and venous thrombosis in a mouse tumor model and in patients with cancer. MATERIALS AND METHODS: We used a human pancreatic cancer cell line HPAF-II that expresses a high level of MUC1...
March 21, 2024: Thrombosis Research
https://read.qxmd.com/read/38531118/antithrombin-exhibits-anticoagulant-effects-on-the-emicizumab-based-engineered-bispecific-antibody-nxt007-mediated-blood-coagulation
#23
LETTER
Yuto Nakajima, Kenichi Ogiwara, Keito Inaba, Takehisa Kitazawa, Keiji Nogami
No abstract text is available yet for this article.
March 21, 2024: Thrombosis Research
https://read.qxmd.com/read/38569453/low-recurrent-thrombosis-rates-in-single-positive-antiphospholipid-syndrome-regardless-of-type-of-anticoagulation
#24
JOURNAL ARTICLE
Brianna R Bakow, Lisa Yanek, Mark A Crowther, Shruti Chaturvedi
Thrombotic antiphospholipid syndrome (TAPS) is characterized by thrombosis and persistently positive tests for antiphospholipid antibodies or lupus anticoagulant (LAC). Triple-positive APS has the highest risk of recurrent thrombosis, but no studies have focused on recurrent thrombosis in patients with single-positive TAPS. We conducted a retrospective cohort study of patients with single-positive TAPS diagnosed at Lifespan Health System, Rhode Island, to determine the rates and risk factors for recurrent thrombosis...
March 20, 2024: Thrombosis Research
https://read.qxmd.com/read/38579513/sepsis-induces-heterogeneous-transcription-of-coagulation-and-inflammation-associated-genes-in-renal-microvasculature
#25
JOURNAL ARTICLE
Matthijs Luxen, Peter J Zwiers, Rianne M Jongman, Jill Moser, Marianne Pultar, Susanna Skalicky, Andreas B Diendorfer, Matthias Hackl, Matijs van Meurs, Grietje Molema
BACKGROUND: Acute kidney injury (AKI) in sepsis patients increases patient mortality. Endothelial cells are important players in the pathophysiology of sepsis-associated AKI (SA-AKI), yet knowledge regarding their spatiotemporal involvement in coagulation disbalance and leukocyte recruitment is lacking. This study investigated the identity and kinetics of responses of different microvascular compartments in kidney cortex in response to SA-AKI. METHODS: Laser microdissected arterioles, glomeruli, peritubular capillaries, and postcapillary venules from kidneys of mice subjected to cecal ligation and puncture (CLP) were analyzed using RNA sequencing...
March 18, 2024: Thrombosis Research
https://read.qxmd.com/read/38552496/comprehensive-investigation-of-platelet-function-in-patients-with-cirrhosis
#26
JOURNAL ARTICLE
Anna Lecchi, Giulia Tosetti, Claudia Ghali, Silvia La Marca, Marigrazia Clerici, Lidia Padovan, Eti A Femia, Massimo Primignani, Vincenzo La Mura, Pietro Lampertico, Flora Peyvandi, Armando Tripodi
Cirrhosis presents with thrombocytopenia and possibly thrombocytopathy. Previous studies exploring platelet function gave conflicting results and most controversies are explained by the variety of methods employed for investigation. We sought to assess in-vitro the overall platelet function in cirrhosis. We investigated 34 patients by using the following tests. (i)Aggregometry. (ii)Measurement of the content of platelet granules. (iii)Cytometric platelet activation. (iv)Plasmatic markers of in-vivo platelet activation...
March 16, 2024: Thrombosis Research
https://read.qxmd.com/read/38555718/cyclophosphamide-vs-rituximab-for-eradicating-inhibitors-in-acquired-hemophilia-a-a-randomized-trial-in-108-patients
#27
JOURNAL ARTICLE
H Lévesque, J F Viallard, E Houivet, B Bonnotte, S Voisin, V Le Cam-Duchez, F Maillot, M Lambert, E Liozon, B Hervier, O Fain, B Guillet, J Schmidt, L E Luca, M Ebbo, N Ferreira-Maldent, A Babuty, L Sailler, P Duffau, V Barbay, S Audia, J Benichou, J Graveleau, Y Benhamou
BACKGROUND: Acquired hemophilia A (AHA) is a rare autoimmune disorder due to autoantibodies against Factor VIII, with a high mortality risk. Treatments aim to control bleeding and eradicate antibodies by immunosuppression. International recommendations rely on registers and international expert panels. METHODS: CREHA, an open-label randomized trial, compared the efficacy and safety of cyclophosphamide and rituximab in association with steroids in patients with newly diagnosed AHA...
March 15, 2024: Thrombosis Research
https://read.qxmd.com/read/38547694/the-incidence-of-venous-thromboembolism-after-curative-colon-cancer-surgery-within-an-enhanced-recovery-after-surgery-programme
#28
JOURNAL ARTICLE
Niklas Nygaard Baastrup, Astrid Kerstine Buch, Anders Kierkegaard Gundestrup, Anna Sofie Friis Olsen, Jakob Kleif, Issam Al-Najami, Ulrik Deding, Claus Anders Bertelsen
AIM: Based on three randomised controlled trials performed more than a decade ago, several national guidelines recommend prolonged venous thromboprophylaxis for 28 days following elective surgery for colon cancer. None of these studies were conducted within enhanced recovery after surgery setting. Newer studies indicate that prolonged prophylaxis might not be necessary with enhanced recovery after surgery. We aimed to provide further evidence to this unresolved discussion. METHOD: Retrospective study of patients undergoing elective surgery for colon cancer stage I-III with enhanced recovery after surgery in the Capital Region of Denmark from 2014 to 2017...
March 15, 2024: Thrombosis Research
https://read.qxmd.com/read/38547692/intrinsic-coagulant-potential-modulates-anticoagulant-efficacy-of-rivaroxaban
#29
LETTER
Cindy Pereira Portela, Guido Stirnimann, Dino Kröll, Alessandro Aliotta, Lucas Veuthey, Maxime G Zermatten, Lorenzo Alberio, Debora Bertaggia Calderara
No abstract text is available yet for this article.
March 15, 2024: Thrombosis Research
https://read.qxmd.com/read/38547691/does-morphine-attenuate-the-inhibition-of-platelet-aggregation-for-both-oral-and-parenteral-p2y12-inhibitors
#30
LETTER
Antonio Landi, Giuseppe Gargiulo, Giovanni Esposito, Gianluca Campo, Simone Biscaglia, Dik Heg, Marco Valgimigli
No abstract text is available yet for this article.
March 15, 2024: Thrombosis Research
https://read.qxmd.com/read/38513536/prognostic-gene-landscapes-and-therapeutic-insights-in-sepsis-induced-coagulopathy
#31
JOURNAL ARTICLE
Xiaoli Ran, Jun Zhang, Yinyu Wu, Yunxia Du, Daiqin Bao, Haoyu Pei, Yue Zhang, Xiaoqiong Zhou, Rui Li, Xu Tang, Han She, Qingxiang Mao
BACKGROUND: Sepsis is a common and critical condition encountered in clinical practice that can lead to multi-organ dysfunction. Sepsis-induced coagulopathy (SIC) significantly affects patient outcomes. However, the precise mechanisms remain unclear, making the identification of effective prognostic and therapeutic targets imperative. METHODS: The analysis of transcriptome data from the whole blood of sepsis patients, facilitated the identification of key genes implicated in coagulation...
March 12, 2024: Thrombosis Research
https://read.qxmd.com/read/38503672/aiming-for-precision-cyp2c19-gene-polymorphism-and-clopidogrel-resistance-in-patients-with-peripheral-artery-disease
#32
JOURNAL ARTICLE
Sina Rashedi, Parham Sadeghipour, Junyang Lou
No abstract text is available yet for this article.
March 8, 2024: Thrombosis Research
https://read.qxmd.com/read/38484630/asundexian-in-atrial-fibrillation-can-pharmacodynamic-data-explain-the-failure
#33
LETTER
Julie Vassart, Marie Didembourg, Laure Morimont, Clotilde Brisbois, Laurent Jamart, Aurélien Lebreton, François Mullier, Nathalie Donis, Julien Favresse, Jean-Michel Dogné, Jonathan Douxfils
No abstract text is available yet for this article.
March 7, 2024: Thrombosis Research
https://read.qxmd.com/read/38484629/the-role-of-coagulation-factors-viii-ix-and-xi-in-the-prediction-and-mediation-of-recurrent-thrombotic-events-in-children-with-non-central-venous-catheter-deep-vein-thrombosis
#34
JOURNAL ARTICLE
Alessandra Bosch, Kirsten Brunsvig Jarvis, Leonardo R Brandão, Yushu Zhou, Jennifer Vincelli, Nour Amiri, Laura Avila
BACKGROUND: The role of elevated coagulation factors VIII (FVIII), FIX, FXI for the prediction of recurrent thrombotic events in children after an index non-central venous catheter (non-CVC) related deep vein thrombosis (DVT) remains unclear. OBJECTIVE: This study investigates the predictive role of FVIII, FIX, and FXI for recurrent thrombosis in children with index non-CVC DVTs, and the mediation effect of FVIII on chronic inflammation and recurrent thrombosis...
March 7, 2024: Thrombosis Research
https://read.qxmd.com/read/38461615/risk-of-thrombosis-hemorrhage-and-leukemic-transformation-in-patients-with-myeloproliferative-neoplasms-a-nationwide-longitudinal-cohort-study
#35
JOURNAL ARTICLE
Joon Young Hur, Nayeon Choi, Jung Hye Choi, Jiyeong Kim, Young-Woong Won
INTRODUCTION: There are few large-scale, population-based studies detailing the risks of thrombosis, hemorrhage, leukemic transformation in patients with myeloproliferative neoplasms (MPNs), including essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (PMF). METHODS: We performed a nationwide longitudinal cohort study using the Korean National Health Insurance System (NHIS) database. MPN patients (n = 11,991) and their 1:4 age- and sex-matched controls (n = 47,964) were enrolled...
March 6, 2024: Thrombosis Research
https://read.qxmd.com/read/38547695/platelet-factor-4-promotes-deep-venous-thrombosis-by-regulating-the-formation-of-neutrophil-extracellular-traps
#36
JOURNAL ARTICLE
Wenqiang Li, Decai Chi, Shuai Ju, Xinyi Zhao, Xiaoyan Li, Junjie Zhao, Huiqi Xie, Yao Li, Jiaqi Jin, Ge Mang, Zhihui Dong
The presence of neutrophil extracellular traps (NETs) in thrombotic diseases has been extensively studied. The exact mechanism of NET formation in deep venous thrombosis (DVT) has not been largely studied. This study is aimed to explore the role of NETs and their interaction with platelet factor 4 (PF4) in DVT. In plasma samples from 51 healthy volunteers and 52 DVT patients, NET markers and PF4 were measured using enzyme-linked immunosorbent assays (ELISA). NET generation in blood samples from healthy subjects and DVT patients was analyzed by confocal microscopy and flow cytometry...
March 5, 2024: Thrombosis Research
https://read.qxmd.com/read/38484628/acute-and-subacute-effects-of-strenuous-exercise-on-platelet-aggregation-coagulation-and-fibrinolysis-in-patients-with-stable-coronary-artery-disease
#37
JOURNAL ARTICLE
Jacobina Kristiansen, Erik L Grove, Tórur Sjúrðarson, Magni Mohr, Steen D Kristensen, Anne-Mette Hvas
INTRODUCTION: Strenuous exercise may occasionally cause coronary thrombosis with myocardial infarction and sudden cardiac death. MATERIALS AND METHODS: Patients with stable coronary artery disease (CAD) (n = 164) and healthy individuals (n = 25) performed strenuous exercise on a bicycle ergometer. Blood was drawn at baseline, immediately after exercise and 2 h later. Platelet aggregation was measured with Multiplate® Analyzer. Thrombin generation was determined using a thrombogram and by measuring prothrombin fragment 1 + 2 (F1 + 2)...
March 5, 2024: Thrombosis Research
https://read.qxmd.com/read/38461614/impact-of-allele-selective-silencing-of-von-willebrand-factor-in-mice-based-on-a-single-nucleotide-allelic-difference-in-von-willebrand-factor
#38
JOURNAL ARTICLE
Yvonne K Jongejan, Noa A Linthorst, Elisa Schrader Echeverri, Sebastiaan N J Laan, Richard J Dirven, James E Dahlman, Bart J M van Vlijmen, Cécile V Denis, Jeroen C J Eikenboom
INTRODUCTION: Von Willebrand factor (VWF) plays a pathophysiological role in hemostatic disorders. Partial inhibition of the VWF gene through small interfering RNA (siRNA)-mediated allele-selective silencing could be a promising therapeutic strategy. For von Willebrand disease, allele-selectively inhibiting dominant-negative VWF-alleles might ameliorate the phenotype. For thrombotic disorders, partial VWF reduction can lower thrombotic risk, while avoiding bleeding. Previously, we demonstrated the feasibility of Vwf-silencing in homozygous C57BL/6J (B6) or 129S1/SvImJ (129S) mice...
March 5, 2024: Thrombosis Research
https://read.qxmd.com/read/38460307/fundamental-considerations-for-designing-endothelialized-in-vitro-models-of-thrombosis
#39
REVIEW
Titus P Lemmens, Vanessa Bröker, Minke Rijpkema, Christopher C W Hughes, Leon J Schurgers, Judith M E M Cosemans
Endothelialized in vitro models for cardiovascular disease have contributed greatly to our current understanding of the complex molecular mechanisms underlying thrombosis. To further elucidate these mechanisms, it is important to consider which fundamental aspects to incorporate into an in vitro model. In this review, we will focus on the design of in vitro endothelialized models of thrombosis. Expanding our understanding of the relation and interplay between the different pathways involved will rely in part on complex models that incorporate endothelial cells, blood, the extracellular matrix, and flow...
March 5, 2024: Thrombosis Research
https://read.qxmd.com/read/38452447/tigecycline-associated-hypofibrinogenemia-a-single-center-retrospective-controlled-study
#40
JOURNAL ARTICLE
Oğuzhan Firat, Emre Kara, Ümit Yavuz Malkan, Kutay Demirkan, Ahmet Çağkan Inkaya
BACKGROUND: Tigecycline-associated hypofibrinogenemia has been reported as an important adverse effect in recent years, but controlled studies minimizing confounding factors are needed. The objective of our study was to assess changes in fibrinogen levels in patients for hospitalization, comparing two antibiotic episodes (tigecycline and other) within the same patients. METHODS: The retrospective, self-controlled case series study was conducted at our University Hospitals...
March 5, 2024: Thrombosis Research
journal
journal
22831
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.